Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06762444

Bump the Lump - Intervention for the Treatment of Globus Pharyngeus

Bump the Lump: Creation and Validation of Speech Language Pathology Intervention for the Treatment of Globus Pharyngeus

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
10 (estimated)
Sponsor
Wake Forest University Health Sciences · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To develop a standardized speech-language pathology treatment protocol to systematically address Globus pharyngeus (GP) as a proof of concept

Detailed description

Globus pharyngeus (GP), often described as a persistent lump or tightness in the throat, accounting for 4% of new referrals to Ear, Nose, and Throat (ENT) clinics. This condition is reported in the literature in up to 46% of healthy individuals and has been shown to significantly impact patients' quality of life. The key diagnostic criteria for GP include at least 12 weeks duration of symptoms without dysphagia or gastroesophageal reflux as the causative symptom, and in the absence of major esophageal motor disorders. While the exact etiology of GP remains elusive, research suggests a multifactorial nature involving physical, psychological, and functional components. Behavioral therapy with a Speech-language pathologist is often recommended as a treatment option for patients with GP. A review of the literature examining SLP interventions for GP shows that SLP treatments lack standardization, leading to inconsistency and limited efficacy across therapeutic interventions. Therefore, there is an urgent need to further investigate behavioral interventions for GP and develop a standardized treatment protocol to address the condition systematically.

Conditions

Interventions

TypeNameDescription
BEHAVIORALSpeech-language pathologist (SLP) protocolThe SLP intervention protocol consists of six components, all of which will be implemented by the treating speech-language pathologist

Timeline

Start date
2025-08-28
Primary completion
2026-08-01
Completion
2026-08-01
First posted
2025-01-07
Last updated
2025-12-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06762444. Inclusion in this directory is not an endorsement.